Welsh Government support for pharmacy now critical says RPS in Wales
The Royal Pharmaceutical Society in Wales has called on the Welsh Health Minister to take further action to support pharmacy teams amid growing pressures from the COVID-19 virus. The calls to action (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 24, 2020 Category: Drugs & Pharmacology Source Type: news

Covid-19: RPS Wales write to Welsh Health Minister
The Royal Pharmaceutical Society in Wales has called on the Welsh Health Minister to take further action to support pharmacy teams amid growing pressures from the COVID-19 virus. The calls to action (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 24, 2020 Category: Drugs & Pharmacology Source Type: news

FDA Move Opens Door to Biosimilar Insulins, Other Biologics FDA Move Opens Door to Biosimilar Insulins, Other Biologics
In a historic shift, FDA transitions regulatory pathway for insulin and other biologics, meaning products deemed'biosimilar'will be able to compete more easily with brands, in theory lowering prices.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 24, 2020 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) Guidance for Industry
Pharmaceutical Quality/Manufacturing Standards (CGMP)/Over-the-Counter (OTC) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 24, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

DermaPharm A/S - 596662 - 03/10/2020
CGMP/Finished Pharmaceuticals/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 24, 2020 Category: Drugs & Pharmacology Authors: Center for Drug Evaluation and Research Source Type: news

Hangzhou Linkeweier Daily Chemicals Co., Ltd. - 595492 - 03/13/2020
CGMP/Finished Pharmaceuticals/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 24, 2020 Category: Drugs & Pharmacology Authors: Center for Drug Evaluation and Research Source Type: news

RPS in Scotland asks for further support and recognition for pharmacy teams
RPS in Scotland has written to the Cabinet Secretary for Health and Sport to thank her and the First Minister for their messages of support on social media at the end of what had been an incredibly ch (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 24, 2020 Category: Drugs & Pharmacology Source Type: news

Chloroquine (Aralen) vs. Hydroxychloroquine (Plaquenil)
Title: Chloroquine (Aralen) vs. Hydroxychloroquine (Plaquenil)Category: MedicationsCreated: 3/24/2020 12:00:00 AMLast Editorial Review: 3/24/2020 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 24, 2020 Category: Drugs & Pharmacology Source Type: news

COVID-19 (coronavirus): Updated information for Community Pharmacies in Wales
The Chief Pharmaceutical Officer for Wales has issued a letter with updated information for community pharmacies. The letter can be accessed here and on our novel coronavirus hub page. If you have a (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 23, 2020 Category: Drugs & Pharmacology Source Type: news

UPDATED INFORMATION: April 21, 2020: Meeting of the Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement - 04/21/2020 - 04/21/2020
April 21, 2020: Meeting of the Pulmonary-Allergy Drugs Advisory Committee Meeting Announcement (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 23, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Drug Trials Snapshots: SARCLISA
Drug Trials Snapshots (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 23, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Biosimilar and Interchangeable Biologics: More Treatment Choices
The medical marketplace keeps growing as the U.S. Food and Drug Administration continues to approve more biosimilar products. Biosimilars can provide more treatment options to patients, potentially lowering costs and increasing access to lifesaving medications. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 23, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

RPS England calls for recognition of pharmacy in COVID-19 response
English Pharmacy Board Chair Claire Anderson has written to the Secretary of State for Health and Social Caretoday, calling for greater recognition of pharmacists and support staff who are going&quot (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 23, 2020 Category: Drugs & Pharmacology Source Type: news

COVID-19 (coronavirus): SOP for Community Pharmacies in England
NHS England has issued an updated Novel coronavirus (COVID-19) standard operating procedure (SOP) for Community Pharmacy. The SOP can be accessed here and on our novel coronavirus hub page. If you h (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 23, 2020 Category: Drugs & Pharmacology Source Type: news

Isturisa (Osilodrostat Tablets, for Oral Use) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 23, 2020 Category: Drugs & Pharmacology Source Type: news

Coronavirus (COVID-19) Update: FDA provides update on patient access to certain REMS drugs during COVID-19 public health emergency
FDA provides update on patient access to certain REMS drugs during COVID-19 (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 22, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Policy for Certain REMS Requirements During the COVID-19 Public Health Emergency Guidance for Industry and Health Care Professionals
FDA is issuing this guidance to communicate its temporary policy for certain risk evaluation and mitigation strategies (REMS) requirements for the duration of the public health emergency (PHE) declared by the Secretary of Health and Human Services (HHS) on January 31, 2020. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 22, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

RPS advice for the public on how they can support pharmacies
RPS has developed advice on ways the public can support their local pharmacies. Pharmacy teams are going above and beyond to ensure patients receive care and medicines, but they need the public’ (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 20, 2020 Category: Drugs & Pharmacology Source Type: news

RPS shares advice for the public on how they can support pharmacies
RPS has adapted advice from the Welsh Governmenton ways the public can support their local pharmacies. Pharmacy teams are going above and beyond to ensure patients receive care and medicines, but they (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 20, 2020 Category: Drugs & Pharmacology Source Type: news

Post Award Grantee Information
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 20, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Volunteering to help during the COVID-19 pandemic
There have been fantastic offers of help from the profession in response to the COVID-19 pandemic. Pharmacy students, pre-registration pharmacists, retired pharmacists and colleagues working in indust (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 20, 2020 Category: Drugs & Pharmacology Source Type: news

Key workers and COVID-19
RPS President Sandra Gidley has written an open letter to Headteachers on the role of pharmacists and support teams as"key workers" during the COVID-19 pandemic. You can download a PDF of t (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 20, 2020 Category: Drugs & Pharmacology Source Type: news

Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)
The Food and Drug Administration (FDA or Agency) plays a critical role in protecting the US from emerging infectious diseases, such as the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support continuity and response efforts to this pandemic. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 20, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19
FDA is aware of news reports stating the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, could worsen coronavirus disease (COVID-19). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 19, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves Epclusa (sofosbuvir/velpatasvir) for Children Ages 6 and Older or Weighing at Least 17 kg with Chronic Hepatitis C Infection
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 19, 2020 Category: Drugs & Pharmacology Source Type: news

Drug Trials Snapshots: LUTATHERA
For the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 19, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Coronavirus: BBC covers frontline pharmacy
BBC London TV have filmed with RPS English Pharmacy Board member Ash Soni in his pharmacy in South London. Ash explains the pressures he and his team are under, working flat out to cope with demand a (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 19, 2020 Category: Drugs & Pharmacology Source Type: news

Drug Trials Snapshots: NURTEC ODT
NURTEC ODT is a drug used for treatment of acute migraine with or without aura in adults. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 19, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic
This guidance provides recommendations to industry regarding postmarketing adverse event reporting for drugs, biologics, medical devices, and dietary supplements during a pandemic. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 19, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Packing down paracetamol
These are unprecedented times. Because of coronavirus, demand for paracetamol is very high but P and GSL packs of paracetamol are hard to get hold of. You’ve asked us if it’s OK to break (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 19, 2020 Category: Drugs & Pharmacology Source Type: news

Drug Development Tool Submissions Process
DDT page (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 19, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections
A U.S. Food and Drug Administration (FDA) safety review has resulted in adding warnings to the labels of a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors about the risks of too much acid in the blood and of serious urinary tract infections. Both conditions can result in hospitalization. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 19, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

COVID-19 Updated information from NHS England
NHS England has produced second of a series of regular updates to community pharmacy regarding the emerging COVID-19 situation. Further details of the letter can be found on the NHS website (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 19, 2020 Category: Drugs & Pharmacology Source Type: news

RPS Scotland welcomes access to the ECS and calls for more support for pharmacists providing frontline services during pandemic
RPS Scotland has today [Wednesday 18 March 2020] welcomed the announcement that pharmacists and pharmacy technicians will be given access to the Emergency Care Summary (ECS) as part of the Scottish Go (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 18, 2020 Category: Drugs & Pharmacology Source Type: news

RPS Scotland welcomes access to the ECS and calls for more support for pharmacists during pandemic
RPS Scotland has today [Wednesday 18 March 2020] welcomed the announcement that pharmacists and pharmacy technicians will be given access to the Emergency Care Summary (ECS) as part of the Scottish Go (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 18, 2020 Category: Drugs & Pharmacology Source Type: news

RPS Wales welcomes Welsh Government Covid-19 community pharmacy response
Responding to a letter sent to all community pharmacies in Wales that details the Welsh Government’s initial response to Covid-19, Chair of the RPS in Wales Suzanne Scott Thomas said:“We (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 18, 2020 Category: Drugs & Pharmacology Source Type: news

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
| Guidance for Industry, Investigators, and Institutional Review Boards (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 18, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

We welcome new NHS England Covid-19 plans
Responding to the letter sent by NHS England/Improvement on measures to further support primary care workers such as pharmacists, Chair of the RPS in England Professor Claire Anderson said:“Th (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 18, 2020 Category: Drugs & Pharmacology Source Type: news

Novel Coronavirus - Anti-inflammatory medications
NHS England has issued advice for all clinical staff on the use of anti-inflammatory medications... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 18, 2020 Category: Drugs & Pharmacology Source Type: news

Veltassa (patiromer)
Title: Veltassa (patiromer)Category: MedicationsCreated: 3/18/2020 12:00:00 AMLast Editorial Review: 3/18/2020 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 18, 2020 Category: Drugs & Pharmacology Source Type: news

Isturisa (Osilodrostat Tablets, for Oral Use) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 18, 2020 Category: Drugs & Pharmacology Source Type: news

Amethia (Lvonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 18, 2020 Category: Drugs & Pharmacology Source Type: news

Janssen Submits Ponesimod New Drug Application to the U.S. FDA for Treatment of Adults with Relapsing Multiple Sclerosis
TITUSVILLE, NEW JERSEY, March 18, 2020– The Janssen Pharmaceutical Companies of Johnson& Johnson (Janssen) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ponesimod for... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 18, 2020 Category: Drugs & Pharmacology Source Type: news

Drug Interactions: What You Should Know
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 17, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Table of Surrogate Endpoints That Were the Basis of Drug Approval or Licensure
FDA ’s surrogate endpoint table provides valuable information for drug developers on endpoints that may be considered and discussed with FDA for individual development programs. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 17, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Your voice in Government on Covid-19
Pharmacy is always demanding but Covid-19 has made it tougher. We’ve heard what you’re asking for and are taking action. We’ll be working with the NHS and governments across the UK (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 17, 2020 Category: Drugs & Pharmacology Source Type: news

Make professional decisions with our backing
Pharmacists and pharmacy teams are working harder than ever to support people with their medicines during the unprecedented and unplanned for impact of COVID-19. The RPS backs you to use your profess (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 17, 2020 Category: Drugs & Pharmacology Source Type: news

Are Warnings Against NSAIDs in COVID-19 Warranted? Are Warnings Against NSAIDs in COVID-19 Warranted?
The French Health Ministry recommends acetaminophen instead, but evidence on any unique COVID-19-related effects linked to ibuprofen is lacking, say the Spanish Health Ministry and a US expert.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 17, 2020 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news

Windlas Healthcare Private Limited - 595494 - 03/10/2020
CGMP/Finished Pharmaceuticals/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 17, 2020 Category: Drugs & Pharmacology Authors: Center for Drug Evaluation and Research Source Type: news

GOJO Industries Inc - 599132 - 01/17/2020
Unapproved New Drugs/Misbranded (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 17, 2020 Category: Drugs & Pharmacology Authors: Center for Drug Evaluation and Research Source Type: news